ecancermedicalscience

Clinical Study

High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease

25 Oct 2018
Carolina Alves, Marcella Mesquita, Carolina Silva, Maria Soeiro, Ludhmila Hajjar, Rachel P Riechelmann

Background: Patients with carcinoid syndrome (CS) may present carcinoid heart disease (CHD) but prognostic factors are not entirely understood.

Patients and Methods: Retrospective study of patients with metastatic neuroendocrine tumours (NETs) and CS and/or abnormal 24-hoururinary 5-hydroxiindolacetic acid. CHD was defined as moderate to severe tricuspid or pulmonary regurgitation in the echocardiogram.

Results: The frequency of CHD among 42 patients was 38% (95% confidence interval [CI]: 23%–54%). CHD was associated with higher volume of liver metastases (odds ratio [OR] 13.86, 95% CI: 2.57–74.68, p = 0.002). Time from CS symptoms to NET diagnosis was borderline significant (p = 0.08). When CHD was defined as at least mild tricuspide regurgitation, the frequency of CHD was 45% and it was associated with cardiovascular comorbidities (OR: 6.58, 95% CI: 1.09; 39.78, p = 0.040).

Conclusion: CHD was frequent among patients with CS, significantly associated with high liver tumour burden, and likely linked to the history of cardiovascular disease and longer time of CS.

Article metrics: 482 views
296
186

Related Articles

Rachel P Riechelmann, Renata D’Alpino Peixoto, Gustavo Dos Santos Fernandes, Rui F Weschenfelder, Gabriel Prolla, Duilio Rocha Filho, Aline Chaves Andrade, Marcela Crosara, Juliana Florinda M Rego, Rene C Gansl, Felipe Coimbra, Samuel Aguiar Jr, Elisângela Carvalho, Paulo M Hoff, Anelisa K Coutinho
Chakra P Chaulagain, Adalberto Gonzalez, Isaac Goldszer, Luis Caraballo, James E Hoffman, Leah Elson, Maria-Julia Diacovo
Tiago Cordeiro Felismino, Victor Hugo Fonseca de Jesus, Bruno Cezar de Mendonça Uchóa Junior, Francisca Giselle Rocha Moura, Rachel P Riechelmann, Samuel Aguiar Junior, Celso Abdon Lopes de Mello